Publications & Presentations

Vectra Da

Publications & Presentations

Multi-Biomarker Disease Activity Score is Associated with Power Doppler Ultrasound in Patients with Rheumatoid Arthritis in Low Disease Activity State

Residual Inflammatory Activity Assessed by a Multi-Biomarker Disease Activity Blood Test is Linked to Structural Damage in RA Patients in Low Disease Activity/Remission and Normal C-Reactive Protein Level.

Multi-Biomarker Disease Activity (Vectra® DA Algorithm) Score is Associated With Power Doppler Ultrasound in Patients With Rheumatoid Arthritis in Low Disease Activity State: The Remira Cohort.

A Multi-Biomarker Disease Activity Blood Test in Patients With Juvenile Idiopathic Arthritis

A multi-biomarker disease activity score tracks clinical response consistently in patients with rheumatoid arthritis

Preliminary Assessment of a Multi-Biomarker Disease Activity Test for Axial Spondyloarthritis

Pre-treatment multi-biomarker disease activity score and radiographic progression in early RA

Vectra DA for the objective measurement of disease activity in patients with rheumatoid arthritis.

A Multibiomarker Disease Activity Score for Rheumatoid Arthritis Predicts Radiographic Joint Damage in the BeSt Study

A Multi-Biomarker Disease Activity Blood Test (Vectra® DA) Correlates with Radiographic Progression in Early Rheumatoid Arthritis: Results from the SWEFOT Trial

©2017 Crescendo Bioscience, Inc. All rights reserved. Vectra, Crescendo Bioscience, MyRA and the associated logos are trademarks or registered trademarks of Crescendo Bioscience, Inc. in the United States and other jurisdictions.